Bolt Biotherapeutics
5 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
Org chart
Randall Schatzman
CEO & Board Member
Randall Schatzman
Collapse
Willie Quinn
Chief Financial Officer
Grant Yonehiro
Chief Business Officer
Michael N. Alonso
VP, Immunology & Pharmacology
Nathan Ihle
VP, CMC & Quality
Wesley Burwell
VP, Head of HR
Sarah Nemec
VP, Finance & Principal Accounting Officer
Lu Xu
VP, Developmental Science
Tai Yu
VP, Regulatory Affairs
Pam Howland
VP, Portfolio & Program Management
Aldwin Aldana Ms, Rqap-Glp, Mrqa
Director, Clinical Quality Assurance (gcp)
Geoff W.
Director Of IT
Lynn Ferguson Lewis
Head Of Information Technology
Senita Greene
Senior Executive Assistant
Dawn Colburn
VP, Clinical Development
Coya Tapia
Medical Director
Arthur Lee
Principal Scientist
Husein Hadeiba
Senior Scientist
